Morgan L Zenner
Overview
Explore the profile of Morgan L Zenner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zenner M, Kirkpatrick B, Leonardo T, Schlicht M, Saldana A, Loitz C, et al.
J Extracell Biol
. 2024 Mar;
2(11).
PMID: 38496750
Prostate cancer is the second leading cause of malignancy-related deaths among American men. Active surveillance is a safe option for many men with less aggressive disease, yet definitively determining low-risk...
2.
Zenner M, Kirkpatrick B, Leonardo T, Schlicht M, Saldana A, Loitz C, et al.
bioRxiv
. 2023 May;
PMID: 37214878
Prostate cancer is the second leading cause of malignancy-related deaths among American men. Active surveillance is a safe option for many men with less aggressive disease, yet definitively determining low-risk...
3.
Moline D, Zenner M, Burr A, Vellky J, Nonn L, Vander Griend D
Am J Clin Exp Urol
. 2023 Jan;
10(6):425-439.
PMID: 36636696
Benign prostate hyperplasia and prostate cancer are common diseases that involve the overgrowth of prostatic tissue. Although their pathologies and symptoms differ, both diseases show aberrant activation of prostate progenitor...
4.
Zenner M, Helou Y, Deaton R, Sverdlov M, Wang H, Kajdacsy-Balla A, et al.
Prostate
. 2021 Dec;
82(3):306-313.
PMID: 34855273
Background: The metabolism of normal prostate relies on glycolysis, with prostate cancer having reduced glycolysis and increased aerobic metabolism. Advanced glycation end products (AGEs) accumulate in tissues as a result...
5.
Zenner M, Baumann B, Nonn L
Curr Opin Endocr Metab Res
. 2020 Oct;
10:50-59.
PMID: 33043165
MicroRNAs are known to be dysregulated in prostate cancer. These small noncoding RNAs can function as biomarkers and are involved in the biology of prostate cancer. The canonical mechanism for...
6.
Richards Z, McCray T, Marsili J, Zenner M, Manlucu J, Garcia J, et al.
iScience
. 2019 Feb;
12:304-317.
PMID: 30735898
The fibromuscular stroma of the prostate regulates normal epithelial differentiation and contributes to carcinogenesis in vivo. We developed and characterized a human 3D prostate organoid co-culture model that incorporates prostate...
7.
Wozniak D, Kajdacsy-Balla A, Macias V, Ball-Kell S, Zenner M, Bie W, et al.
Nat Commun
. 2017 Nov;
8(1):1508.
PMID: 29142193
PTEN activity is often lost in prostate cancer. We show that the tyrosine kinase PTK6 (BRK) is a PTEN substrate. Phosphorylation of PTK6 tyrosine 342 (PY342) promotes activation, while phosphorylation...